Eng, Jennifer http://orcid.org/0000-0003-1499-8417
Bucher, Elmar http://orcid.org/0000-0002-2929-2460
Hu, Zhi
Zheng, Ting
Gibbs, Summer L.
Chin, Koei http://orcid.org/0000-0001-8061-7462
Gray, Joe W. http://orcid.org/0000-0001-9225-6756
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (1R44 CA224994, U54 CA209988, U2C CA233280, U54 CA209988, U2C CA233280, P30 CA69533)
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
Prospect Creek Foundation
Article History
Received: 23 April 2021
Accepted: 14 April 2022
First Online: 11 May 2022
Competing interests
: J.W.G. has licensed technologies to Abbott Diagnostics; has ownership positions in Convergent Genomics, Health Technology Innovations, Zorro Bio, and PDX Pharmaceuticals; serves as a paid consultant to New Leaf Ventures; has received research support from Thermo Fisher Scientific (formerly FEI), Zeiss, Miltenyi Biotech, Cepheid (Danaher), Quantitative Imaging, Health Technology Innovations, and Micron Technologies; and owns stock in Abbott Diagnostics, AbbVie, Alphabet, Amazon, Amgen, Apple, General Electric, Gilead, Intel, Microsoft, Nvidia, and Zimmer Biomet. S.L.G. has received research support from Quantitative Imaging. The remaining authors declare no competing interests.